BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2018
View Archived Issues
New method to up fetal hemoglobin
Read More
A new take on targeting Wnt
Read More
Red blood cell hitchhiking improves nanocarrier drug delivery to specific target organs
Read More
Tau protein can be targeted by small drug-like molecules to avoid aggregation
Read More
In vivo studies show potential of CSTI-300 for irritable bowel syndrome-diarrhea
Read More
Phase 0 results presented for tau-imaging tracer [18F]JNJ-067
Read More
Evaluation of [11C]BU-99008 as a marker for AD pathology mechanisms
Read More
Kinase inhibitor targets leishmaniasis
Read More
First patient dosed in phase I study of TP-0184 for the treatment of advanced solid tumors
Read More
Positive topline data presented from pivotal study of dasotraline in binge eating disorder
Read More
Researchers unveil mechanism of action of the antiplatelet compound LASSBio-788
Read More
BeiGene initiates Chinese phase III trial of first-line tislelizumab therapy for advanced NSCLC
Read More
Researchers prove NE-driven feeding-suppression circuit in mice
Read More
Mitobridge describes new ACMSD inhibitors
Read More
Intra-Cellular Therapies identifies mu-opioid receptor antagonists
Read More
New phosphodiesterase PDE2A inhibitors presented by Dart NeuroScience
Read More
Shanghai Fochon Pharmaceutical Co., Fochon Pharma patent Bcl-2 inhibitors
Read More
Henan Metab Biopharma divulges Mcl-1 inhibitors
Read More
ALTA-1L phase III study of brigatinib meets primary endpoint
Read More
Bioasis announces positive results from microdialysis mouse study of xB3-001
Read More
Corbus plans phase III trial of lenabasum in dermatomyositis
Read More
Destiny Pharma reports encouraging phase I safety data for XF-73
Read More
Phase I study data support biosimilarity criteria of GBR-310 to reference omalizumab
Read More
Phase Ib safety data for OPT-302 in DME support progression to phase IIa
Read More
FDA places clinical hold on phase I/IIa DMD trial due to out-of-specification production lot
Read More
